2D vs. 3D laparoscopic anterior resection: a randomised controlled trial

Yeovil District Hospital NHS Foundation Trust0 sites88 target enrollmentDecember 16, 2015

Overview

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30656453 results (added 13/03/2019) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31567928/ Factors predicting operative difficulty (added 10/01/2023)

Registry

who.int

Start Date

December 16, 2015

End Date

April 30, 2018

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Sponsor

Yeovil District Hospital NHS Foundation Trust

•1\. Patients diagnosed with adenocarcinoma of the rectum (\<15cm from anal verge as measured by staging MRI )
•2\. Scheduled to undergo elective laparoscopic TME/ partial mesorectal excision surgery with curative intent, with or without neo\-adjuvant treatment and with or without defunctioning stoma formation
•3\. Written informed patient consent

•1\. History of inflammatory bowel disease
•2\. Patients requiring abdomino\-perineal excision or surgery without anastomosis
•3\. Advanced tumours involving adjacent organs (TNM5 T4aNxMx)
•4\. Surgery performed with palliative intent or under unplanned/emergency settings
•5\. Previous treatment (radiotherapy/abdominopelvic surgery) for endometrial, ovarian, prostate, bladder (TURBT ok), anal or vaginal cancer
•6\. Patient or surgeon refusal to enter study or accept randomisation result